Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

NCT01380756 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Hematologic Malignancies
Leukemia
Myeloid Leukemia

Interventions

DRUG: Arm 1- Dose Escalation
DRUG: Arm 2- Dose Expansion

Sponsor

Amgen